Physician profile
Benjamin Hutton Stephens
NPI 1043624448
$5,420.62
in general payments reported to CMS, 2019-2025
17 companies · $1,435 in 2025
The $1,435 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $23.11 · 2021: $128 · 2022: $491 · 2023: $1,233 · 2024: $1,486 · 2025: $1,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,154.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,654.00 | 2019-2025 | Clareon, Hydrus Microstent, Acrysof Iq Panoptix Uv Iol |
| Glaukos Corporation | $1,102.45 | 2022-2025 | Idosetr, Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb Americas INC. | $512.75 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Abbvie INC. | $484.67 | 2022-2025 | Vuity, Lumigan, Alphagan P |
| Harrow Eye, LLC | $404.92 | 2024-2025 | Vevye |
| Allergan, INC. | $392.02 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $329.19 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $164.29 | 2023-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Sight Sciences, INC. | $117.75 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Aerie Pharmaceuticals, INC. | $81.90 | 2019-2021 | |
| Shire North American Group INC | $39.56 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $37.41 | 2023 | Tecnis Iol |
| Mallinckrodt Hospital Products INC. | $35.43 | 2023-2024 | Acthar |
| Thea Pharma INC. | $17.58 | 2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.42 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $16.35 | 2019 | |
| Omeros Corporation | $13.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.